Eugia Pharma  receives a warning letter from FDA which summarizes significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals.

U.S. Food and Drug Administration (FDA) inspected a drug manufacturing facility of Eugia Pharma Specialities Limited (Unit III), at Patancheru (Mandal), Sangareddy, Hyderabad, Telangana, from January 22 to February 2, 2024. It is a wholly owned subsidiary of the Aurobindo Pharma.

Indoco Remedies receives final ANDA approval from the USFDA  for Lofexidine Tablets 0.18 mg with Competitive Generic Therapy designation, It is a generic equivalent of Lucemyra Tablets, 0.18 mg of USWM, LLC.

Institute of Nano Science and Technology, Mohali, Punjab, an autonomous institution of Department of  Science and Technology, Government of India, has been established under the umbrella of NANO MISSION, initiated by DST to boost research and development in the field of Nanoscience and Nanotechnology in India. INST started its activities on 3rd January 2013, the date on which its first Director was appointed.

Government Primary Health Centers Government Medical College Hospital, Ariyalur and District Health Office, (Government Primary Health Centres) are inviting applications for the following vacancies on daily wages and salary basis under the National Health Group Scheme in Ariyalur District under District Siddha Medical Division.

Post : Dispenser

Tata Memorial Centre is an autonomous grant-in-aid institution of the Department of Atomic Energy.   TMC is comprised of the Advanced Centre for Treatment, Research and Education in Cancer ( ACTREC) and the   Tata Memorial Hospital (  TMH). ACTREC conducts a Ph.D. program in Life   Sciences, affiliated to the Homi Bhabha National Institute (a deemed university under category A by MHRD, Govt of India). On-going research at ACTREC includes basic and translational research in Cancer Biology.